NEULAND LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,488 INR | -1.52% |
|
+3.01% | +22.71% |
| May. 14 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 | |
| May. 10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 996M | - | - | ||||
| 791B | ||||||
| 630B | ||||||
| 328B | ||||||
| 298B | ||||||
| 246B |
